International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AR) Argentina: Muforan;
-
(AT) Austria: Muphoran;
-
(AU) Australia: Muphoran;
-
(BE) Belgium: Muphoran;
-
(BG) Bulgaria: Mustophoran;
-
(BR) Brazil: Muphoran;
-
(CN) China: Jiang zhi | Muphoran;
-
(CZ) Czech Republic: Mustophoran;
-
(EE) Estonia: Muphoran;
-
(ES) Spain: Mustoforan;
-
(FR) France: Fotemustine Dci | Muphoran;
-
(GR) Greece: Muphoran;
-
(HK) Hong Kong: Muphoran;
-
(HU) Hungary: Mustophoran;
-
(IT) Italy: Muphoran;
-
(LT) Lithuania: Mustophoran;
-
(LV) Latvia: Muphoran;
-
(PL) Poland: Mustophoran;
-
(PT) Portugal: Muphoran;
-
(RU) Russian Federation: Mustophoran;
-
(SI) Slovenia: Muphoran;
-
(SK) Slovakia: Mustophoran;
-
(TR) Turkey: Muphoran;
-
(UA) Ukraine: Mustophoran
Pharmacologic Category
-
Antineoplastic Agent;
-
Antineoplastic Agent, Alkylating Agent (Nitrosourea)
Reported Use
Treatment of disseminated malignant melanoma and early stage malignant brain tumors
Dosage Range
Adults: IV/Intra-arterial:
Induction: 100 mg/m2 once weekly for 3 weeks as a single agent or 100 mg/m2 once weekly for 2 weeks as part of a combination chemotherapy regimen.
Maintenance: 100 mg/m2 once every 3 weeks. Begin 4 to 5 weeks after the last induction dose (blood counts permitting).
Product Availability
Product available in various countries; not currently available in the US
Dosage Forms
Solution Reconstituted, Injection: 208 mg